Free Trial

Climb Bio (CLYM) Institutional Ownership

Climb Bio logo
$1.26 -0.08 (-5.97%)
As of 05/1/2025 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Climb Bio (NASDAQ:CLYM)

Current
Institutional Ownership
Percentage
69.76%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$754.85K
Number of
Institutional Sellers
(last 12 months)
0
Get CLYM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Climb Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Climb Bio Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/30/2025 Peapod Lane Capital LLC553,816$676K0.8%N/A0.821%
4/29/2025 Bank of New York Mellon Corp64,914$79K0.0%N/A0.096%
(Data available from 1/1/2016 forward)

CLYM Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CLYM shares?

During the previous two years, the following institutional investors and hedge funds held shares of Climb Bio shares: Peapod Lane Capital LLC ($676K), Bank of New York Mellon Corp ($79K).Learn more on CLYM's institutional investors.

What percentage of Climb Bio stock is owned by institutional investors?

69.76% of Climb Bio stock is owned by institutional investors. Learn more on CLYM's institutional investor holdings.

Which institutional investors have been buying Climb Bio stock?

The following institutional investors have purchased Climb Bio stock in the last 24 months: Peapod Lane Capital LLC ($553.82K), and Bank of New York Mellon Corp ($64.91K).

How much institutional buying is happening at Climb Bio?

Institutional investors have bought a total of 618,730 shares in the last 24 months. This purchase volume represents approximately $754.85K in transactions.



This page (NASDAQ:CLYM) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners